期刊
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY
卷 15, 期 2, 页码 317-323出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1932296819882425
关键词
CGM; children; CSII; dermatological complications; type 1 diabetes; quality of life
资金
- Aage Bangs fund
- Aase and Ejnar Danielsen's fund
- Else and Mogens Wedell-Wedellsborg's fund
A Danish study showed that most pediatric patients using continuous subcutaneous insulin infusion experience dermatological complications, impacting their health-related quality of life. Factors like age, gender, BMI, and HbA1c levels were not significantly associated with dermatological complications, but patients perceiving these complications as a greater problem had lower HrQoL scores. Additional preventive studies are needed to address this issue.
Background: A Danish study showed that 90% of the pediatric patients who participated had some time experienced dermatological complications due to treatment with continuous subcutaneous insulin infusion (CSII). This follow-up study describes dermatological complications due to CSII and/or continuous glucose monitoring (CGM) between the two study periods and includes health-related quality of life (HrQoL) measurements. Methods: A total of 138 patients (95%) out of 145 patients from the initial study answered an online questionnaire regarding dermatological complications related to CSII and/or CGM, five months later. A second questionnaire (DISABKIDS) regarding HrQoL was sent out to those 138 of which 111 patients completed it. The patients were aged from 2 to 20 years. Descriptive statistics, chi(2) tests, and univariate and multivariate analyses were used to analyze the data. Results: In total, 81% of the 138 patients continued to have dermatological complications at follow-up. Itching was the most frequently reported complication. Patients using Enlite reported more dermatological complications than those using Libre. In total, 79% of the patients who used barrier cream in the initial study still had dermatological complications five months later. Age, gender, Body Mass Index (BMI), or HbA1c levels showed no significant association with dermatological complications. Patients who perceived dermatological complications as a greater problem had lower HrQoL scores. Conclusion: Once dermatological complications start to appear, they become chronic, indicating that the treatments currently available are inadequate. Patients perceiving dermatological complications as a greater problem were associated with lower HrQoL. These findings highlight the need for additional preventive studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据